Impedimed (ASX:IPD)
ASX announcement history & article coverage
Transparent by design.
Announcments by Impedimed (ASX:IPD) are listed here, whether we covered it or not. Where we've written an article, you'll see it linked directly. Where we haven't, the filing is still shown so nothing is hidden from view. If you think a particular announcement deserved editorial coverage and was overlooked, you can flag it for review and our team will take a look.
Annual General Meeting - Online Meeting Guide
Notice of Annual General Meeting & Voting Form
Application for quotation of securities - IPD
Notice of Initial Substantial Holder
Change of Director's Interest Notice - Mr Erik Anderson
Update on Options
Date of 2026 Annual General Meeting
Appendix 4G and Corporate Governance Statement
2026 Annual Report
ImpediMed reports 15% revenue growth, expands SOZO platform, completes $15.3M capital raise
Appendix 4E
FDA Clearance for Sarcopenia Risk Assessment Received
ImpediMed's SOZO Platform Gains FDA Clearance for Sarcopenia Risk Assessment
ASX Listing Rule 7.16 Compliance
Notification of cessation of securities - IPD
Investor Presentation
Quarterly Activities Report and Appendix 4C - Jun-2026 Qtr
ImpediMed reports Q4 FY26 revenue growth, $15.3 million capital raise, and strategic progress in cancer survivorship and heart health
Notification of Q4 FY26 Quarterly Results Investor Webinar
Notification of cessation of securities - IPD